# US 2004/0063182 A1 · Process for producing prenyl alcohol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0063182 A1
- Document ID: US20040063182A1
- Status: Published application
- Kind: A1
- Application number: 10/450,941
- Filed: 2003-06-18
- Published: 2004-04-01
- Earliest claimed: 2000-12-28
- Inventors: Chikara Ohto; Shusei Obata
- Web page: https://patentgrep.com/patent/US20040063182A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 9/90: Isomerases (5.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/81: for yeasts
- C12P 7/04: acyclic
- C07K 2319/00: Fusion polypeptide
- C07K 2319/02: containing a signal sequence
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method of producing a prenyl alcohol(s), comprising culturing a mutant cell that has been mutated so that an amount of squalene synthase gene transcript having translational activity can be reduced, and recovering the prenyl alcohol(s) from the resultant culture.

## Claims

### Claim 1

A method of producing a prenyl alcohol(s), comprising culturing a mutant cell that has been mutated so that an amount of squalene synthase gene transcript having translational activity can be reduced, and recovering the prenyl alcohol(s) from the resultant culture.

### Claim 2

A method of producing a prenyl alcohol(s), comprising preparing a recombinant by introducing a recombinant DNA for expression or a DNA for genomic integration each comprising an IPP biosynthetic pathway-related enzyme gene into a mutant cell that has been mutated so that an amount of squalene synthase gene transcript having translational activity can be reduced, culturing the resultant recombinant, and recovering the prenyl alcohol(s) from the resultant culture.

### Claim 3

A method of producing a prenyl alcohol(s), comprising culturing a mutant cell in which the transcription promoter region of its squalene synthase gene has been replaced with a transcription repression-type promoter under transcription repression conditions; reducing an amount of squalene synthase gene transcript having translational activity; and recovering the prenyl alcohol(s) from the resultant culture.

### Claim 4

A method of producing a prenyl alcohol(s), comprising preparing a recombinant by introducing a recombinant DNA for expression or a DNA for genomic integration each comprising an IPP biosynthetic pathway-related enzyme gene into a mutant cell in which the transcription promoter region of its squalene synthase gene has been replaced with a transcription repression-type promoter so that an amount of squalene synthase gene transcript having translational activity can be reduced, culturing said recombinant under transcription repression conditions; and recovering the prenyl alcohol(s) from the resultant culture.

### Claim 5 (depends on 3, 4)

The method according to claim 3 or 4, wherein the transcription repression-type promoter is GAL1 promoter.

### Claim 6 (depends on 3, 4)

The method according to claim 3 or 4, wherein the transcription repression conditions comprise the use of a glucose-containing medium.

### Claim 7 (depends on 2, 4)

The method according to claim 2 or 4, wherein the IPP biosynthetic pathway-related enzyme gene is any one selected from the group consisting of the following genes (a) through (l):
(a) farnesyl diphosphate synthase gene
(b) geranylgeranyl diphosphate synthase gene
(c) hydroxymethylglutaryl-CoA reductase gene
(d) isopentenyl diphosphate Δ-isomerase gene
(e) mevalonate kinase gene
(f) acetyl-CoA acetyltransferase gene
(g) hydroxymethylglutaryl-CoA synthase gene
(h) phosphomevalonate kinase gene
(i) diphosphomevalonate decarboxylase gene
(j) a mutant of any one of the above genes (a) through (i)
(k) a fusion gene composed of a gene selected from the group consisting of the above genes (a) through (i) or a mutant thereof, and other gene or a mutant thereof
(l) a gene obtained by introducing an addition, substitution or insertion mutation into any one of the above genes (a) through (k) so that the polypeptide encoded by the resultant gene contains an endoplasmic reticulum signal.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the endoplasmic reticulum signal is represented by the sequence shown in SEQ ID NO: 30, 31 or 32.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method according to any one of claims 1 to 8, wherein the cell is yeast.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the yeast is Saccharomyces cerevisiae.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the Saccharomyces cerevisiae is Saccharomyces cerevisiae A451 strain, YPH499 strain, YPH500 strain, W303-1A strain or W303-1B strain.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method according to any one of claims 1 to 11, wherein the prenyl alcohol(s) are/is farnesol, nerolidol and/or geranylgeraniol.

### Claim 13 (depends on 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any one of claims 3 to 12, wherein the cell is cultured under non-transcription repression conditions prior to the cultivation under transcription repression conditions.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the transcription repression conditions comprise the use of a glucose-containing medium and the non-transcription repression conditions comprise the use of a galactose-containing medium.

### Claim 15 (depends on 7)

The method according to claim 7, wherein the farnesyl diphosphate synthase gene encodes the amino acid sequence as shown in SEQ ID NO: 2 or 4.

### Claim 16 (depends on 7)

The method according to claim 7, wherein the geranylgeranyl diphosphate synthase gene encodes the amino acid sequence as shown in SEQ ID NO: 6.

### Claim 17 (depends on 7)

The method according to claim 7, wherein the hydroxymethylglutaryl-CoA reductase gene encodes the amino acid sequence as shown in SEQ ID NO: 8.

### Claim 18 (depends on 7)

The method according to claim 7, wherein the mutant of hydroxymethylglutaryl-CoA reductase gene comprises the nucleotide sequence as shown in any one of SEQ ID NOS: 11, 13 and 15 through 24.

### Claim 19 (depends on 7)

The method according to claim 7, wherein the diphosphomevalonate decarboxylase gene encodes the amino acid sequence as shown in SEQ ID NO: 10.

### Claim 20

A mutant cell that has been mutated so that an amount of squalene synthase gene transcnpt having translational activity can be reduced.

### Claim 21

A mutant cell in which the transcription promoter region of its squalene synthase gene has been replaced with a transcription repression-type promoter so that an amount of transcript from its squalene synthase gene having translational activity can be reduced.
